Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The two screenshots show the same record history entries with no added or removed versions; the content on the page remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-02T04:55:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-25T21:36:03.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3 from the revision history.
    Difference
    0.1%
    Check dated 2026-03-18T18:21:43.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history; Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:29:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.2; the funding-status notice and Revision: v3.4.1 entry were removed.
    Difference
    0.6%
    Check dated 2026-02-11T02:12:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and operating-status information, directing users to cc.nih.gov and opm.gov for updates. The history now shows Revision: v3.4.1 and removes Revision: v3.4.0.
    Difference
    0.6%
    Check dated 2026-02-03T23:57:00.000Z thumbnail image

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.